喉上神经阻滞治疗神经源性咳嗽的疗效分析
本研究通过回顾性病历分析,评估喉上神经(SLN)阻滞治疗难治性神经源性咳嗽的短期与长期疗效,并探讨其与喉镜所见的关系。结果显示,短期随访患者咳嗽严重指数(CSI)显著下降;伴有声带运动/振动异常(VFA)的患者在短期和长期均显示改善趋势,而无VFA者无显著改善。结论认为SLN阻滞有效,VFA可能是疗效预测指标。
要点
- 无VFA患者短期CSI无统计学显著改善。
核心结论
- SLN阻滞治疗神经源性咳嗽有效,与既往文献一致。
- VFA的存在可能提示患者获得更好的治疗效果。
研究设计与样本
- 回顾性病历分析,纳入2018至2020年接受SLN阻滞的20例患者,排除4例记录不完整者。
- 适应症为药物和/或咳嗽抑制治疗难治的神经源性咳嗽。
主要发现
- 无VFA者短期CSI无统计学显著改善。
临床怎么用
- 对于难治性神经源性咳嗽,可考虑SLN阻滞作为治疗选择。
- 喉镜下发现VFA可能有助于筛选可能获益的患者。
局限性
- 回顾性设计,样本量小(20例),证据等级为4级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study aimed to add to the body of evidence for efficacy of Superior Laryngeal Nerve (SLN) blocks for treatment of neurogenic cough. Efficacy at short- and long-term intervals are presented as well as relationships with laryngoscopic findings. METHODS: A retrospective chart review of patients treated with SLN block between 2018 and 2020 was conducted. Patient demographics, videostroboscopic findings, and patient-subjective perception of outcomes were recorded and analyzed. Cough Severity Index (CSI) scores from pre-injection, short-term follow-up, and long-term follow-up were compared. RESULTS: Twenty patients underwent SLN block in the clinic setting. Four patients were excluded for incomplete records. The indication was neurogenic cough refractory to medical management and/or cough suppression therapy. Patients with short-term follow-up (n = 13) had statistically significant decrease in CSI scores, with a mean baseline CSI of 24.3 decreasing to 16.15 (P = .006). Patients with evidence of Vocal Fold Motion/Vibratory Abnormalities (VFA) (n = 8) showed improvement in short-term CSI scores, with a mean baseline CSI of 24.13 decreasing to 14.5 (P = .004). Those without evidence of VFA did not have statistically significant improvement in short-term CSI scores. At long-term follow-up, patients with VFA had improvements that approached statistical significance with a mean baseline CSI of 22.56 decreasing to 14.56 (P = .057), while patients without VFA showed no improvement. CONCLUSIONS: Our results are consistent with previous literature indicating efficacy of SLN block. The presence of VFA may be an indicator of patients who experience increased therapeutic effect. LEVEL OF EVIDENCE: 4 Laryngoscope, 131:E2676-E2680, 2021.
引用
- Duffy JR, Litts JK, Fink DS, et al. Superior Laryngeal Nerve Block for Treatment of Neurogenic Cough. Laryngoscope. 2021. PMID: 33894012. doi:10.1002/lary.29585
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。